Bridget Larkin

587 total citations
8 papers, 468 citations indexed

About

Bridget Larkin is a scholar working on Immunology, Parasitology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bridget Larkin has authored 8 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 5 papers in Parasitology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bridget Larkin's work include Parasites and Host Interactions (5 papers), Research on Leishmaniasis Studies (4 papers) and interferon and immune responses (2 papers). Bridget Larkin is often cited by papers focused on Parasites and Host Interactions (5 papers), Research on Leishmaniasis Studies (4 papers) and interferon and immune responses (2 papers). Bridget Larkin collaborates with scholars based in United States, Netherlands and Belgium. Bridget Larkin's co-authors include Vladimir Ilyukha, Maxim Sorokin, Alexander Poltorak, Edouard Vannier, Anton Buzdin, Miguel J. Stadecker, Mara G. Shainheit, Patrick M. Smith, Laura I. Rutitzky and Holly Ponichtera and has published in prestigious journals such as The Journal of Immunology, Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

Bridget Larkin

7 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bridget Larkin United States 5 301 156 138 136 77 8 468
Mirjam M. Mebius Netherlands 8 101 0.3× 91 0.6× 92 0.7× 45 0.3× 24 0.3× 8 300
Lucas Kraemer Brazil 13 101 0.3× 165 1.1× 84 0.6× 32 0.2× 39 0.5× 29 402
Shengjun Lu China 9 225 0.7× 109 0.7× 45 0.3× 22 0.2× 47 0.6× 18 381
Wojciech Wojciechowski United States 9 236 0.8× 43 0.3× 70 0.5× 72 0.5× 23 0.3× 13 418
Lisa M. Connor New Zealand 11 386 1.3× 55 0.4× 87 0.6× 89 0.7× 20 0.3× 18 511
J N Woody United States 12 357 1.2× 69 0.4× 117 0.8× 26 0.2× 30 0.4× 22 566
Yusuke Sayama Japan 16 174 0.6× 53 0.3× 165 1.2× 52 0.4× 55 0.7× 41 562
Julie Osborne United Kingdom 14 186 0.6× 278 1.8× 62 0.4× 360 2.6× 54 0.7× 16 835
Tracy L. Keiser United States 10 230 0.8× 50 0.3× 71 0.5× 144 1.1× 187 2.4× 13 521
Joeli Brinkman United States 13 180 0.6× 82 0.5× 180 1.3× 20 0.1× 53 0.7× 16 559

Countries citing papers authored by Bridget Larkin

Since Specialization
Citations

This map shows the geographic impact of Bridget Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Larkin more than expected).

Fields of papers citing papers by Bridget Larkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Larkin. The network helps show where Bridget Larkin may publish in the future.

Co-authorship network of co-authors of Bridget Larkin

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget Larkin. A scholar is included among the top collaborators of Bridget Larkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget Larkin. Bridget Larkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Singh, Sanjaya, Danlin Yang, Joseph A. Erhardt, et al.. (2025). Abstract 7325: Pharmacologic characterization of a highly specific and potent CLDN6xCD3 T cell engager (TCE), ARC101, for the treatment of CLDN6+ cancers. Cancer Research. 85(8_Supplement_1). 7325–7325.
2.
Larkin, Bridget, Vladimir Ilyukha, Maxim Sorokin, et al.. (2017). Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death. The Journal of Immunology. 199(2). 397–402. 273 indexed citations
3.
Poltorak, Alexander, et al.. (2015). The role of STING in T lymphocytes (IRM5P.643). The Journal of Immunology. 194(1_Supplement). 59.8–59.8. 2 indexed citations
4.
Ponichtera, Holly, Mara G. Shainheit, Beiyun C. Liu, et al.. (2014). CD209a Expression on Dendritic Cells Is Critical for the Development of Pathogenic Th17 Cell Responses in Murine Schistosomiasis. The Journal of Immunology. 192(10). 4655–4665. 29 indexed citations
5.
Larkin, Bridget, Moustapha Mbow, Lynn Meurs, et al.. (2012). Th17 cells are associated with pathology in human schistosomiasis (43.24). The Journal of Immunology. 188(1_Supplement). 43.24–43.24. 1 indexed citations
6.
Mbow, Moustapha, Bridget Larkin, Lynn Meurs, et al.. (2012). T-Helper 17 Cells Are Associated With Pathology in Human Schistosomiasis. The Journal of Infectious Diseases. 207(1). 186–195. 77 indexed citations
7.
Larkin, Bridget, Patrick M. Smith, Holly Ponichtera, et al.. (2012). Induction and regulation of pathogenic Th17 cell responses in schistosomiasis. Seminars in Immunopathology. 34(6). 873–888. 44 indexed citations
8.
Shainheit, Mara G., Eduardo Finger, Bridget Larkin, et al.. (2011). The Pathogenic Th17 Cell Response to Major Schistosome Egg Antigen Is Sequentially Dependent on IL-23 and IL-1β. The Journal of Immunology. 187(10). 5328–5335. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026